National Health Investors, Inc.

UNDERVALUEDNHI · NYSE · Real Estate
NHI·NYSE·Real Estate
UNDERVALUED
National Health Investors, Inc.
27.1%upside
MARKET PRICE
$70.42
FAIR PRICE
$89.49
MARGIN
$19.07
UNDERVALUEDFAIROVERVALUED
P/E RATIO
22.5x
DIV. YIELD
6.70%
ROE
9.8%
MARKET CAP
$3B
FPI
fairpriceindex.com

FAIR PRICE VALUATION

27.1%upside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$70.42

FAIR PRICE

$89.49

MARGIN

$19.07

UNDERVALUEDFAIROVERVALUED

P/E Ratio

22.5x

What is P/E? →

Div. Yield

6.70%

ROE

9.8%

Average

Market Cap

$3B

Mid-cap

NOW AVAILABLE

Get notified when NHI's fair price changes

Push notifications when NHI's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

6.4/ 10

Strong profitability and low debt levels, but limited growth momentum.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$71.59CONSERVATIVE ENTRY
$89.49FAIR PRICE
$70.42MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$71.59

Fair price × 0.80

DISTANCE

1.7%

Price to entry level

At the current price of $70.42, NHI trades 1.7% below the conservative entry level of $71.59. The stock is currently priced below the 20% margin of safety threshold, indicating a potential value opportunity based on the model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate NHI's fair price

National Health Investors, Inc.'s fair price of $89.49 is derived from a blended model that combines DCF analysis (50%), relative valuation against Real Estate peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $70.42, NHI trades 27.1% below its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting NHI's risk profile.

RELATIVE · 30%

Comparing NHI's valuation multiples against Real Estate peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for NHI, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate NHI's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for NHI.

Explore on Bulios

FAQ

What is the fair price of NHI?+

Based on our blended model combining DCF analysis (50%), relative valuation against Real Estate peers (30%), and analyst consensus (20%), the fair price for National Health Investors, Inc. is $89.49. At the current market price of $70.42, NHI trades 27.1% below its calculated fair value.

Is NHI overvalued or undervalued?+

National Health Investors, Inc. is currently undervalued based on our valuation model. The stock trades at $70.42, which is 27.1% below the fair price of $89.49. The P/E ratio of 22.5x is a key metric in the valuation.

What is the margin of safety for NHI?+

With a 20% margin of safety applied to the fair price of $89.49, the conservative entry level for NHI is $71.59. At the current market price of $70.42, the stock trades 1.7% below this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is NHI's fair price updated?+

We update fair price calculations for NHI daily after market close. The current fair price of $89.49 incorporates the latest market data and sector multiples.

What factors affect NHI's fair price calculation?+

NHI's fair price of $89.49 is derived from DCF analysis (50% weight), relative valuation against Real Estate peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 22.5x, ROE of 9.8%, and dividend yield of 6.70%.

Is NHI a good buy right now?+

At $70.42, NHI trades 27.1% below our fair value estimate of $89.49. The stock is currently undervalued. ROE stands at 9.8% (average). Fair Price Index provides valuation data — always do your own research before investing.

Does NHI pay dividends?+

NHI has a dividend yield of 6.70%.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.